UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recommandations du groupe Fi-LMC pour la gestion des effets indésirables du traitement par nilotinib (Tasigna®) au cours de la leucémie myéloïde chronique

Bulletin du cancer, 2010-08, Vol.97 (8), p.997-1009

2010

Volltextzugriff (PDF)

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi( )-LMC GROUP)

Leukemia, 2006-06, Vol.20 (6), p.1061-1066

2006

Volltextzugriff (PDF)

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

Leukemia, 2004-10, Vol.18 (10), p.1711-1716

2004

Volltextzugriff (PDF)

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

Leukemia, 2012-10, Vol.26 (10), p.2254-2259

2012

Volltextzugriff (PDF)

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

Haematologica (Roma), 2007-09, Vol.92 (9), p.1238-1241

2007

Volltextzugriff (PDF)

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis

Leukemia, 2006-02, Vol.20 (2), p.350-353

2006

Volltextzugriff (PDF)

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

The New England journal of medicine, 2017-03, Vol.376 (10), p.917-927

2017

Volltextzugriff (PDF)

Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows

Haematologica (Roma), 2007-05, Vol.92 (5), p.597-604

2007

Volltextzugriff (PDF)

Plasmocytomes cutanés associés au virus Epstein-Barr chez les transplantés d’organes

Annales de dermatologie et de vénéréologie, 2004-12, Vol.131 (12), p.1085-1091

2004

Volltextzugriff (PDF)

The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders

Leukemia, 2008-02, Vol.22 (2), p.450-451

2008

Volltextzugriff (PDF)

Role of Hemophagocytic Histiocytosis in the Etiology of Thrombocytopenia in Patients with Sepsis Syndrome or Septic Shock

Clinical infectious diseases, 1997-11, Vol.25 (5), p.1159-1164

1997

Volltextzugriff (PDF)

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

The New England journal of medicine, 2010-06, Vol.362 (24), p.2251-2259

2010

Volltextzugriff (PDF)

Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas

The Journal of biological chemistry, 1994-03, Vol.269 (12), p.8944-8951

1994

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients

British journal of haematology, 1996-06, Vol.93 (3), p.731-736

1996

Volltextzugriff (PDF)

Guidelines for the management of nilotinib (Tasigna)-induced side effects in chronic myelogenous leukemia: recommendations of French Intergroup of CML (Fi-LMC group)

Bulletin du cancer, 2010-08, Vol.97 (8), p.997

2010

Volltextzugriff (PDF)

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

The New England journal of medicine, 2010-12, Vol.363 (26), p.2511-2521

2010

Volltextzugriff (PDF)

Toxidermies induites par les nouveaux inhibiteurs spécifiques de la tyrosine-kinase de BCR-ABL dans le traitement des leucémies à chromosome Philadelphie

Annales de dermatologie et de vénéréologie, 2011-12, Vol.138 (12), p.A91-A92

2011

Volltextzugriff (PDF)

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Blood, 2008-04, Vol.111 (8), p.4022-4028

2008

Volltextzugriff (PDF)

Maladie de Castleman et carcinome chromophobe du rein : Une association fortuite?

Annales de pathologie (Paris), 1998, Vol.18 (5), p.429-431

1998

Volltextzugriff (PDF)

Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice

Blood, 2002-11, Vol.100 (10), p.3495

2002

Volltextzugriff (PDF)

Leucémie aiguë à mastoblastes révélée par des bouffées vasomotrices

Annales de dermatologie et de vénéréologie, 1997-09, Vol.124 (9), p.621-622

1997

Volltextzugriff (PDF)

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

The New England journal of medicine, 2003-03, Vol.348 (11), p.994-1004

2003

Volltextzugriff (PDF)

Épanchement pleural éosinophile associé à un syndrome de Churg et Strauss

Revue de pneumologie clinique, 2008-10, Vol.64 (5), p.229-233

2008

Volltextzugriff (PDF)

Erythema annulare centrifugum and Hodgkin's disease

Annales de dermatologie et de vénéréologie, 1990, Vol.117 (11), p.889-890

1990

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGastroentérologie Clinique Et Biologique

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(157)
Französisch
(91)

Erscheinungsjahr

n.n

Thema

Humans
(144)
Science & Technology
(110)
Life Sciences & Biomedicine
(109)
Male
(91)
Female
(83)
Biological And Medical Sciences
(72)
Adult
(66)
Medical Sciences
(63)
Middle Aged
(62)
Aged
(49)
Hematology
(43)
Hematologic And Hematopoietic Diseases
(32)
Animals
(28)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Oncology
(23)
Adolescent
(20)
Bone Marrow - Pathology
(19)
Sciences Biologiques Et Medicales
(17)
Sciences Medicales
(17)
Benzamides
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recommandations du groupe Fi-LMC pour la gestion des effets indésirables du traitement par nilotinib (Tasigna®) au cours de la leucémie myéloïde chronique

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi( )-LMC GROUP)

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows

Plasmocytomes cutanés associés au virus Epstein-Barr chez les transplantés d’organes

The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders

Role of Hemophagocytic Histiocytosis in the Etiology of Thrombocytopenia in Patients with Sepsis Syndrome or Septic Shock

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients

Guidelines for the management of nilotinib (Tasigna)-induced side effects in chronic myelogenous leukemia: recommendations of French Intergroup of CML (Fi-LMC group)

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Toxidermies induites par les nouveaux inhibiteurs spécifiques de la tyrosine-kinase de BCR-ABL dans le traitement des leucémies à chromosome Philadelphie

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Maladie de Castleman et carcinome chromophobe du rein : Une association fortuite?

Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice

Leucémie aiguë à mastoblastes révélée par des bouffées vasomotrices

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Épanchement pleural éosinophile associé à un syndrome de Churg et Strauss

Erythema annulare centrifugum and Hodgkin's disease

Aktive Filter

Suchergebnisse filtern